Assessment of SOX10 expression in 437 canine neoplasms of different embryologic origins
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.SOX10 protein is expressed in various canine tumors beyond melanoma, including mammary carcinomas and gliomas. Its presence in some oral sarcomas limits its diagnostic use for melanoma.
Area Of Science
- Veterinary Pathology
- Oncology
- Molecular Biology
Background
- SOX10 protein is a known marker for melanoma diagnosis in humans.
- Its expression in canine neoplasms requires further investigation.
- SOX10 plays a role in neural crest cell development and tumorigenesis.
Purpose Of The Study
- To characterize SOX10 expression in a wide range of canine neoplasms.
- To evaluate the diagnostic utility of SOX10 as an immunohistochemical marker in dogs.
- To determine if SOX10 is expressed in non-melanoma canine tumors.
Main Methods
- Immunohistochemistry (IHC) was performed on 437 canine tumor tissues.
- Tissues represented various embryologic origins: ectodermal, mesodermal, endodermal, and mixed/unknown.
- Canine melanomas served as positive controls.
Main Results
- SOX10 was highly expressed in most ectodermal tumors, including mammary carcinomas and gliomas.
- Mesodermal and endodermal tumors generally lacked SOX10 expression.
- Inconsistent SOX10 expression was noted in some oral fibrosarcomas and undifferentiated oral sarcomas.
Conclusions
- SOX10 expression is not exclusive to canine melanomas and occurs in diverse tumor types.
- The presence of SOX10 in a subset of oral sarcomas complicates its use as a specific marker for spindle cell oral melanomas.
- Further research is needed to understand the full diagnostic implications of SOX10 in canine cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
